Histiocytic Neoplasms

2

Review clinical trials related to Histiocytic Neoplasms. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Ulixertinib in People With Histiocytic Neoplasms

The researchers are doing this study is to find out whether ulixertinib is an effective and safe treatment for people with histiocytic neoplasms.

Participants needed: 38
Trial details
Phase: Phase 2Age: 12+Biological sex: AllType: InterventionalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: May 28, 2026Locations: 8
Eligibility criteria

Histologically confirmed histiocytic neoplasm or histologic findings consistent... [+24]

Uncontrolled or severe intercurrent medical condition [+12]

Status: Recruiting

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

The purpose of this study is to determine the uptake of the imaging agent \[68Ga\]-pentixafor with PET/CT scans in people with monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), and non-Hodgkin lymphoma (NHL), or you have histiocytic neoplasms (Langerhans cell histiocytosis (LCH), Erdheim-Chester disease (ECD) and/or Rosai-Dorfman disease (RDD).

Participants needed: 30
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Feb 5, 2026Locations: 1
Eligibility criteria

Indolent B- or T-cell Non-Hodgkin lymphoma (including cutaneous lymphomas) or No... [+6]

Breast-feeding [+2]